Palantir Technologies Inc. (PLTR) — closed signal from May 16, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on August 14, 2026.
Predicted vs. what happened
PLTR price · publication thesis → realized outcomesplit-adjusted
$128.00 – $136.00Entry zone — fair-value band
$133.99Published — price the day we called it
$158.11Target — the price the thesis aimed for
$180.18Peak — highest point inside the window, not a realized return
$174.04Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 16 days.
Peak price
$180.18
peak on August 14, 2026 — not a realized returnPeak gain
+34.5%
peak, from the publication priceWindow close
$174.04
end-of-window price, context onlyDays to target
16
Window
May 16, 2026 – August 14, 2026
The thesis — published May 16, 2026
Predicted growth
+18%
over the measurement windowTarget price
$158.11
the price the thesis aimed forEntry zone
$128.00 – $136.00
the fair-value band we waited forPrice at publication
$133.99
published May 16, 2026Confidence
69%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Palantir showed stronger Q1 results and raised revenue guidance for 2026, keeping it positioned as an AI-focused software company. A healthy balance sheet and steady demand from government and businesses support potential upside. However, high valuation, insider selling, and recent profit-taking in AI stocks make this a cautious recovery setup for the next 0-3 months.
Primary drivers
- Q1 update and higher 2026 guidance reinforce AI demand story
- Healthy balance sheet reduces short-term financial risk
- Government and commercial use remain main growth drivers
- High valuation and AI-sector selling constrain conviction
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.